![](https://www.genengnews.com/wp-content/uploads/2024/07/CO_MarApr17_Getty_182516812_Henrik5000_BlueCells-1068x801-1.jpg)
StockWatch: As Illumina Expands in Multiomics, Analyst Sees Threat to 10x
When Illumina (ILMN) announced its acquisition of Fluent BioSciences, it did not say how much it shelled out for the privately held single-cell technology developer in a deal that catapulted the longtime leader in next-generation sequencing into the faster …